Only "Independent Expert’s preferred value of a ResApp share", these T/O are usually "premium" from a big pharma so....
- Forums
- ASX - By Stock
- RAP
- Ann: Pfizer raises scheme consideration to A$0.208 per share
Ann: Pfizer raises scheme consideration to A$0.208 per share, page-3
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)